Twist Bioscience's Chief Legal: What Investors Need to Know
A senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
This primer highlights crypto types considered safer for newcomers and outlines practical steps to assess risk and suitability for your first investments.
20,867 articlesA senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
A growing online debate over Roth vs Traditional 401(K) strategies is getting a reality check. Experts say the decisi...
As 2026 unfolds, three robotics stocks stand out in the M&A spotlight, driven by cash flow, autonomous tech stacks, a...
Six months after a December 2025 spotlight, Vanguard’s overlooked Monthly Income ETF VWOB still delivers reliable mon...
Nebius Group shows a dramatic jump in revenue as AI demand accelerates. This article explains the drivers, checks the...
SpaceX opened at $160.95 per share and briefly topped a $2 trillion valuation on debut, then pulled back to more mode...
The first half of 2026 delivered a housing market that steadied into a new normal. Here are the five lessons that def...
ARKK charges a 0.75% annual fee that quietly drags returns. This article explains the cost, contrasts with cheaper pe...
A kitchen-renovation boom masks a hidden health hazard for fabricators. This report outlines how your quartz countert...
A seismic shift in how the Fed communicates could redefine market expectations. This piece examines kevin warsh shift...
Emerging markets can boost growth, but they come with unique risks. This guide explains what to consider before addin...
The AI hardware boom is fading as demand cools, dragging optical and memory stocks lower and prompting investors to r...